Novo Nordisk and HFA Collaboration: Hopeful Future for Hemophilia B
Hemophilia Federation of America (HFA) shared a reminder post on X:
”Time is running out to register!
Join us tomorrow, July 29 ,at 7pm ET for Living with Hemophilia B: From Challenges to Hopeful Futures, an interactive virtual event presented in partnership with Novo Nordisk.”
Register now.
In collaboration with Novo Nordisk, the Hemophilia Federation of America (HFA) will host a virtual presentation on July 29 at 7 p.m. EST, led by Dr. Robert Sidonio.
This interactive session will explore the everyday challenges faced by individuals living with hemophilia B and provide a platform for open dialogue around personal experiences, treatment roadblocks, and future hopes for disease management.
With a focus on community engagement and patient-centered care, the event aims to foster shared understanding and highlight evolving needs in hemophilia B care.
Do not miss any conference or webinar on hemophilia management, read Hemostasis Today.
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
-
Jan 9, 2026, 06:12James Caldwell on The Hidden Culprit in Perimesencephalic SAH
-
Jan 8, 2026, 05:51Dominika Jędrzejewska Akbaş Links Sleep Deprivation, Obesity, and Stroke
-
Jan 8, 2026, 05:42Rob Maloney: A Bruise that Did Not Go Away…
-
Jan 8, 2026, 05:33Matías J Alet on Treating Early Neurological Deterioration in Lacunar Stroke